intranasal glutathione in parkinson's disease nanotherapeutics for brain targeting and clinical studies Nose-to-Brain Nanocarrier Systems in Parkinson's
Description
2020;208 doi: 10.1016/j.neuroimage.2019.116450
n = 12) or placebo (n = 10) for 4 wks
Care 22 , 407412 (2019)
It gives you more than just a brighter skin tone
